Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine

Ildiko Lingvay; Paul C. Norwood; Kamilla Begtrup; Irene H. Langbakke; Marsha Haynes; Federico C. Pèrez Manghi

首页> 外文期刊>Canadian journal of diabetes >Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine

【24h】

Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine

机译：用胰岛素Degludec / Liraglutide治疗2型糖尿病患者具有较大的机会，没有低血糖和体重增加的血糖靶点而不是与胰岛素狼原体

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Canadian journal of diabetes》 |2018年第5期|共1页
作者
Ildiko Lingvay; Paul C. Norwood; Kamilla Begtrup; Irene H. Langbakke; Marsha Haynes; Federico C. Pèrez Manghi;
展开▼
作者单位

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

Mississauga ON;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine [J] . Ildiko Lingvay, Paul C. Norwood, Kamilla Begtrup, Canadian journal of diabetes . 2018,第5期

机译：用胰岛素Degludec / Liraglutide治疗2型糖尿病患者具有较大的机会，没有低血糖和体重增加的血糖靶点而不是与胰岛素狼原体
2. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial. [J] . Stephen C L Gough, Anuj Bhargava, Rajeev Jain, Diabetes care . 2013,第9期

机译：低体积胰岛素Degludec 200单位/ ml每天一次改善血糖控制，与胰岛素 - 野患者2型糖尿病患者的低血糖风险低，有26周，随机，控制，跨国，治疗到目标试用：开始低卷试验。
3. Improvement of glycemic control without severe hypoglycemia in a type?1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec [J] . Takahashi Nobuyuki, Tsujimoto Tetsuro, Inoue Kaori, Journal of diabetes investigation. . 2016,第5期

机译：1型糖尿病患者从甘精胰岛素转变为地高地松胰岛素后，在没有严重低血糖的情况下改善血糖控制，而没有进行严重的低血糖
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Severe Hypoglycemia, Risk of Recurrent Events and Weight Gain on Insulin Therapy in Patients with Type 1 Diabetes Mellitus. [D] . Liu, Zhiwen. 2011

机译：1型糖尿病患者的严重低血糖症，复发事件的风险和胰岛素治疗的体重增加。
6. Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec [O] . Nobuyuki Takahashi, Tetsuro Tsujimoto, Kaori Inoue, 2016

机译：1型糖尿病患者从甘精胰岛素转变为地高地松胰岛素后在没有严重低血糖的情况下改善血糖控制而无严重低血糖
7. Low-Volume Insulin Degludec 200 Units/mL Once Daily Improves Glycemic Control Similarly to Insulin Glargine With a Low Risk of Hypoglycemia in Insulin-Naive Patients With Type 2 Diabetes: A 26-week, randomized, controlled, multinational, treat-to-target trial: The BEGIN LOW VOLUME trial [O] . Gough, SCL, Bhargava, A, Jain, R, 2013

机译：低剂量地高胰岛素Degludec 200单位/ mL每日一次可改善血糖控制，类似于初治2型糖尿病患者低血糖的低血糖风险的甘精胰岛素：为期26周的随机，对照，跨国，针对性治疗试用：BEGIN LOW VOLUME试用

Patients with Type 2 Diabetes Treated with Insulin Degludec/Liraglutide Have a Greater Chance of Reaching Glycemic Targets Without Hypoglycemia and Weight Gain Than with Insulin Glargine

著录项

引文网络

相似文献

相关主题

期刊订阅